Sanofi and Cipla enters into distribution partnership to expand reach of CNS portfolio in India
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
The Cabinet has approved budgetary support of Rs. 2207.50 crore in the 15th Finance Commission Cycle to run CAPFIMS as a campus of AIIMS, New Delhi.
The institution will be spread over an area of more than 8 acres
The investment will catalyse various components of the IndiaAI Mission
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Subscribe To Our Newsletter & Stay Updated